The National Comprehensive Cancer Network (NCCN) provides guidelines for the management of women with a BRCA1 or BRCA2 mutation.2 Prophylactic mastectomy and chemoprevention are both options for cancer risk reduction and should be discussed. Here, BRCA2 is linked to cancer.